PAMU
FOLD

Pictet Asset Management (UK)’s Amicus Therapeutics FOLD Stock Holding History

Pictet Asset Management (UK)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3.88M Buy
402,854
+21,120
+6% +$206K ﹤0.01% 910
2021
Q1 		$3.77M Sell
381,734
-1,248,249
-77% -$19.3M ﹤0.01% 889
2020
Q4 		$37.6M Sell
1,629,983
-70,512
-4% -$1.44M 0.05% 361
2020
Q3 		$24M Sell
1,700,495
-309,101
-15% -$4.51M 0.04% 404
2020
Q2 		$30.3M Buy
2,009,596
+17,944
+0.9% +$219K 0.05% 325
2020
Q1 		$18.4M Sell
1,991,652
-1,685,642
-46% -$16M 0.04% 392
2019
Q4 		$35.8M Sell
3,677,294
-102,648
-3% -$940K 0.06% 334
2019
Q3 		$30.3M Hold
3,779,942
– – 0.06% 317
2019
Q2 		$47.2M Buy
3,779,942
+308,100
+9% +$3.91M 0.1% 242
2019
Q1 		$47.2M Buy
3,471,842
+654,896
+23% +$8M 0.1% 248
2018
Q4 		$27K Buy
2,816,946
+176,533
+7% +$1.94M 0.07% 320
2018
Q3 		$31.9M Buy
2,640,413
+477,702
+22% +$6.68M 0.07% 319
2018
Q2 		$33.8M Buy
2,162,711
+367,714
+20% +$5.56M 0.08% 293
2018
Q1 		$27M Buy
+1,794,997
New +$27.3M 0.07% 333
2016
Q3 		– Sell
-4,707,381
Closed -$33.3M – 836
2016
Q2 		$33.3M Buy
4,707,381
+4,099,881
+675% +$28.7M 0.13% 212
2016
Q1 		$3.74M Sell
607,500
-356,135
-37% -$2.52M 0.02% 591
2015
Q4 		$9.35M Buy
963,635
+148,112
+18% +$1.33M 0.04% 416
2015
Q3 		$11.4M Sell
815,523
-45,063
-5% -$707K 0.05% 373
2015
Q2 		$14.8M Buy
860,586
+266,377
+45% +$3.2M 0.06% 349
2015
Q1 		$5.98M Buy
594,209
+59,504
+11% +$525K 0.02% 549
2014
Q4 		$4.45M Buy
+534,705
New +$3.67M 0.02% 603

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management (UK)'s FOLD Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Amicus Therapeutics (FOLD) stake by 5.5% in Q2 2021, buying an estimated $206K and bringing the position to 402,854 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #910.

Pictet Asset Management (UK) first reported a position in FOLD in Q4 2014 and has held it in 21 quarters since. The position peaked at $47.2M in Q1 2019. 235 funds tracked by Wall St. Rank hold FOLD as of Q2 2021.

  • Pictet Asset Management (UK) held 402,854 shares of Amicus Therapeutics worth $3.88M as of Q2 2021.
  • Pictet Asset Management (UK) bought 21,120 Amicus Therapeutics shares in Q2 2021, an estimated $206K.
  • Amicus Therapeutics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #910 holding.
  • Pictet Asset Management (UK) first reported a position in Amicus Therapeutics in Q4 2014 and has held it in 21 quarters since.
  • Pictet Asset Management (UK)'s Amicus Therapeutics position peaked at $47.2M in Q1 2019.
  • 235 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.